AVTX Avalo Therapeutics
- 10.8500
- -0.6400-5.57%
- 10.7493
- -0.1007-0.93%
Avalo Therapeutics News
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction.
Express News | Avalo Therapeutics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $35 Price Target
Express News | Avalo Therapeutics Shares up 6.0% Premarket After Oppenheimer Raises to Outperform From Perform
Express News | Avalo Therapeutics : Oppenheimer Raises to Outperform From Perform
Express News | Oppenheimer Upgrades Avalo Therapeutics to Outperform, Announces $35 Price Target
Avalo Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/16/2024 118.07% Oppenheimer → $35 Upgrades Perform → Outperform 06/27/2023 — Oppenheimer Downgrades Ou
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $
SOL, MESO and ACOR Among Pre-market Losers
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersMSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million. Serina Therapeutics (AMEX:SER) stock moved up
Press Release: Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced the addition of multiple biotech leaders to its Board of Directors.
Express News | Avalo Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected FY23 EPS Results
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersGalera Therapeutics (NASDAQ:GRTX) shares moved upwards by 62.8% to $0.23 during Monday's pre-market session. The market value of their outstanding shares is at $12.3 million. As per the news, t
Express News | Friday Avalo Therapeutics Said Cash Balance Of $7.4M And Capital Raise Of $185M In March 2024 Is Expected To Provide Cash Runway Into 2027
Express News | Friday Avalo Therapeutics Reported FY2023 EPS $(114.00) Misses $(96.00) Estimate, Sales $1.92M Beat $1.70M Estimate
Avalo Therapeutics EPS of -$114.00, Revenue of $1.92M Beats by $0.72M
Press Release: Avalo Reports 2023 Financial Results and Provides Business Updates
Avalo Reports 2023 Financial Results and Provides Business Updates -- Acquired AVTX-009, Phase-2 ready anti-IL-1 mAb, in March 2024 -- Increased cash position with private placement financing i
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday's pre-market session. The market value of their outstanding shares is at $14.8 million. Xilio Therapeutics (NASDAQ:XLO
Trending Stocks Today: Medpace Gets a 18.76% Boost Post-Market
March 28th - US stocks trending post-market.Gainers: $Medpace(MEDP.US)$ jumps 18.76% to $480 with a turnover of $13.88 million. Losers: $CleanSpark(CLSK.US)$ declines 13.48% to $18.35 with a turnover
Top Midday Gainers
Avalo Therapeutics (AVTX) shares skyrocketed amid heavy trading Thursday after the company completed the acquisition of privately held AlmataBio and said late Wednesday it entered into a private place
Trending Stocks Today: Avalo Therapeutics Surges 381.05%
March 28th - US stocks trending in regular trading hours.Gainers: $Avalo Therapeutics(AVTX.US)$ soars 381.05% to $22.85 with a turnover of $506.08 million. $Xilio Therapeutics(XLO.US)$ surges 130.04%
Analysis
Price Target
No Data
